David J. Cohen - Concepedia

Author

David J. Cohen

Virginia Commonwealth University ORCID

Also Known As

D COHEN, D Cohen, D J Cohen, D Joshua Cohen, D. Cohen, D. Cohen,, D. J. Cohen, D. Joshua Cohen, D.J. Cohen, David Cohen

136

Publications

Citations

H-Index

117

Concepts

All Affiliations

Virginia Commonwealth University The University of Texas Health Science Center at San Antonio Georgia Institute of Technology The Wallace H. Coulter Department of Biomedical Engineering Shaare Zedek Medical Center

About

David J. Cohen is an author at Virginia Commonwealth University specializing in medicine, cell biology, and biomedical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	30	1.5K
2	Engineering	10	10	615
3	Allergy	2	2	30
4	Arts	1	1	67
5	Health Sciences	1	1	38

David J. Cohen

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro Richard S. Finn, Judy Dering, Dylan Conklin, Breast Cancer Research	2009	1.4K
Additively manufactured 3D porous Ti-6Al-4V constructs mimic trabecular bone structure and regulate osteoblast proliferation, differentiation and local factor production in a porosity and surface roughness dependent manner Alice Cheng, Aiza Humayun, David J. Cohen, Biofabrication Tissue EngineeringOsteoblast ProliferationEngineeringBone RepairBiofabrication	2014	256
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried, The Lancet AsthmaUncontrolled Atopic DermatitisAtopic DermatitisPediatricsClinical Dermatology	2022	242
Acute mastoiditis — the antibiotic era: a multicenter study Michał Luntz, Alexander Brodsky, S. Nusem, International Journal of Pediatric Otorhinolaryngology Acute MastoiditisAntimicrobial StewardshipAntibioticsMast Cell DisorderInfection Control	2001	216
Dacomitinib (PF-00299804), an Irreversible Pan-HER Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib Ondrej Kalous, Dylan Conklin, Amrita Desai, Molecular Cancer Therapeutics Human EgfBreast OncologyOncologyIrreversible Pan-her InhibitorMedicine	2012	84
Controlled release of rat adipose-derived stem cells from alginate microbeads Shirae K. Leslie, David J. Cohen, Janina Sedlaczek, Biomaterials Tissue EngineeringRegenerative MedicineEngineeringMedicineBiofabrication	2013	71
Novel Osteogenic Ti-6Al-4V Device For Restoration Of Dental Function In Patients With Large Bone Deficiencies: Design, Development And Implementation David J. Cohen, Alice Cheng, Adrian Kahn, Scientific Reports	2016	70
Novel hydrophilic nanostructured microtexture on direct metal laser sintered Ti-6Al-4V surfaces enhances osteoblast response<i>in vitro</i>and osseointegration in a rabbit model Sharon L. Hyzy, Alice Cheng, David J. Cohen, Journal of Biomedical Materials Research Part A Tissue EngineeringCnc MillingEngineeringMechanical EngineeringBiomaterials Design	2016	69
RANDOMISED STUDY OF MYRINGOTOMY, AMOXYCILLIN/CLAVULANATE, OR BOTH FOR ACUTE OTITIS MEDIA IN INFANTS Dan Engelhard, Nurith Strauss, L. Jorczak-Sarni, The Lancet Pediatric OtolaryngologyAudiologyOtolaryngologyPediatricsOtorhinolaryngology	1989	67
Performance of laser sintered Ti–6Al–4V implants with bone-inspired porosity and micro/nanoscale surface roughness in the rabbit femur David J. Cohen, Alice Cheng, Kaan Sahingur, Biomedical Materials	2017	58

Page 1